Trial Profile
A Prospective, Multicenter, Randomized, Open-Label, Controlled Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With Mastergraft Granules in Subjects Undergoing Posterolateral Lumbar Fusion With Instrumentation
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 03 Jun 2020
Price :
$35
*
At a glance
- Drugs Rexlemestrocel-L (Primary)
- Indications Intervertebral disc degeneration; Spinal stenosis
- Focus Adverse reactions
- Sponsors Mesoblast
- 21 Nov 2014 New trial record